Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
NCT Number: NCT00152906
A minority of patients with colorectal liver metastases and hepatobiliary cancer (primary liver cancer) are candidates for surgery, but there are no curative treatment options for these patients. Their median survival time is 3 to 12 months. Stereotactic radiation (SRT) (highly conformal radiotherapy (CRT)) is a treatment option for these patients with unresectable liver cancer, now possible due to improvements in our ability to localize and immobilize liver tumors and an improved understanding of the partial liver volume tolerance to radiation. SRT should permit liver tumors to be treated to tumorcidal doses while sparing the uninvolved liver, decreasing the risk of treatment related normal tissue toxicity. With such conformal radiation, it is possible to deliver radiation in fewer fractions than traditionally required, which should be more convenient for patients. In this study, CRT will be delivered during shallow breathing or breath hold to minimize organ motion due to breathing, decreasing the volume of normal liver that must be irradiated.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Toronto, Ontario, M5G 2M9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SRT or CRT is radiation delivered precisely conforming the high dose region to the tumor, usually in a few highdose fractions.
Time frame: assessment: weekly during treatment; 1, 3, 6, 9, 12 months post, every 6 months for up to 3 years
Time frame: assessment: weekly during treatment; 1, 3, 6, 9, 12 months post, every 6 months for up to 3 years
Time frame: assessment: weekly during treatment; 1, 3, 6, 9, 12 months post, every 6 months for up to 3 years
Time frame: assessment: pre-treatement, 1, 3, 6,12 months post
Time frame: 3 to 12 months
Time frame: during radiation treatment only
Time frame: at 3 months post RT
Time frame: baseline, during radiation and up to 3 months post radiation
University Health Network, Toronto
Other
Phase I/II Trial of Highly Conformal Radiotherapy for Unresectable Liver Metastases and Hepatobiliary Carcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01307878
Chemotherapy; Maternal, Affecting Fetus, Colonic Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05261113
Adenocarcinoma, Carcinoma
Regensburg, Germany
View Trial DetailsNCT02456285
Colonic Diseases, Colorectal Neoplasms
Manchester, United Kingdom
View Trial DetailsNCT01177007
Adenocarcinoma, Carcinoma
Baltimore, Maryland, United States
View Trial Details